Summary. Bilateral, pressing headaches that develop after rapidly ascending above 2,500m elevation are most commonly High-Altitude Headache and represent the most frequent initial symptom of acute mountain sickness (AMS). Although typically resolving within 24 hours after descending, the presence of altered consciousness, gait disturbance, or dyspnea at rest may signal life-threatening high-altitude cerebral edema (HACE) or pulmonary edema (HAPE). This article first reviews ICHD-3 diagnostic criteria and evidence-based prevention and management strategies from a headache specialist’s perspective, followed by practical self-management guidance for patients.
Medical Background — Why Does Your Head Hurt at High Altitude?
As elevation increases, atmospheric pressure decreases, lowering the partial pressure of oxygen in inspired air (hypoxia). This hypoxic stimulus causes cerebral vasodilation, activates the trigeminovascular system, and triggers mild cerebral edema and changes in intracranial pressure (International Classification of Headache Disorders, 3rd edition; Cephalalgia 2018). The resulting pain constitutes high-altitude headache, classified as secondary headache (hypoxia- and hypotension-related) under 10.1.1 High-Altitude Headache in the International Classification of Headache Disorders (ICHD-3).
Typical features include: ① Usually bilateral (frontal and temporal regions), ② dull, pressing quality or throbbing, ③ mild to moderate intensity, ④ worsens with bending, straining, coughing, or exertion. Incidence varies greatly depending on ascent rate, final altitude reached, and individual susceptibility.
Diagnosis and Differential — ICHD-3 Criteria and Acute Mountain Sickness
ICHD-3 diagnostic criteria for high-altitude headache (10.1.1) incorporate the following: (A) Occurs after ascent to ≥2,500m elevation, (B) Clear temporal relationship with ascent (worsens with continued climbing, resolves within 24 hours upon descent below 2,500m), (C) Not better explained by another diagnosis. The key clinical clue is a course of “appeared after climbing and improved upon descent.”
High-altitude headache may occur in isolation but commonly presents as part of Acute Mountain Sickness (AMS). In the 2018 revised Lake Louise score, AMS is diagnosed when headache is present along with at least one additional symptom from the following: nausea or anorexia, fatigue or weakness, or dizziness. Therefore, when headache occurs at altitude, accompanying symptoms must also be assessed.
Important differential considerations: ① Thunderclap headache reaching maximum intensity within one minute requires first ruling out emergencies such as subarachnoid hemorrhage. ② Presence of focal neurological deficits such as unilateral weakness, speech disturbance, or diplopia, severe ataxia, or altered consciousness extends beyond simple high-altitude headache and raises suspicion for High-Altitude Cerebral Edema (HACE) or cerebrovascular events, necessitating immediate descent and emergency care. ③ Patients with a history of migraine may experience migraine attacks triggered at altitude; comparison with baseline patterns is helpful.
Self-Management and Prevention — Ascend Gradually, Hydrate Adequately
The cornerstone of prevention is gradual altitude acclimatization. Wilderness Medical Society guidelines recommend that above 3,000m, the sleeping altitude should increase by approximately 500m or less per day, with a rest day every 1,000m ascent or every 3–4 days (Luks et al.). The principle of “climb high, sleep low” is also useful.
Additional practical measures include: Avoid dehydration through adequate fluid intake, and avoid strenuous exercise and alcohol during the first 1–2 days after arrival. For pain relief, simple analgesics such as ibuprofen, acetaminophen, or aspirin are effective; notably, ibuprofen has been shown to aid both prevention and treatment of high-altitude headache (Gertsch et al., 2012). For those with a history of recurrent or severe AMS, or when rapid ascent is unavoidable, consultation with a physician may warrant consideration of prophylactic acetazolamide (125mg, twice daily). The most reliable treatment remains always descent to lower altitude.
Warning Signs — When to Descend and Seek Emergency Care Immediately
If any of the following occurs, the condition may not be simple high-altitude headache, and prompt descent and medical assistance are essential.
- Ataxia with stumbling gait, altered consciousness such as confusion, obtundation, or somnolence (→ High-Altitude Cerebral Edema HACE suspected)
- Dyspnea, dry cough, pink frothy sputum, or cyanosis of lips even at rest (→ High-Altitude Pulmonary Edema HAPE suspected)
- Severe and persistent headache unresponsive to analgesics, recurrent vomiting
- Focal neurological symptoms such as unilateral weakness, dysarthria, or visual disturbance
- Thunderclap headache reaching explosive intensity within one minute
HACE and HAPE are emergencies that can rapidly deteriorate and require immediate descent along with oxygen therapy, dexamethasone (HACE), and additional oxygen/descent measures (HAPE).
Conclusion
High-altitude headache is a relatively predictable headache that “develops with ascent and improves with descent,” yet it can simultaneously signal the onset of more dangerous altitude illness. Before undertaking summer mountain climbing or high-altitude travel, maintain the fundamentals: ascend slowly, rest adequately, and hydrate sufficiently, and keep warning signs in mind. If you have a history of recurrent high-altitude headaches or previous AMS, establishing an individualized prevention strategy through pre-departure consultation with a headache or travel medicine specialist is prudent.
This article provides general medical information and does not replace individual diagnosis or treatment. If symptoms are severe or persistent, medical evaluation is essential.